Abimiku Alash'Le
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Abimiku Alash'Le has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Adam Abdullahi
University of Cambridge
1 shared publication BeiswangerChristine M.
1 shared publication- Christian M. Beiswanger
Independent Consultant
1 shared publication - Colette Smith
Institute for Global Health, University College London, London, UK
1 shared publication - Emmanuel Jonathan
International Research Center of Excellence Institute of Human Virology Nigeria Plot 252 Herbert Macaulay Way Central Business District, Abuja, 900211, Nigeria
1 shared publication - Ezenwa James Onyemata
International Research Center of Excellence Institute of Human Virology Nigeria Plot 252 Herbert Macaulay Way Central Business District, Abuja, 900211, Nigeria
1 shared publication
Latest Publications
- Open Access
- 4 October 2023
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 109 (4) , 890-894
Performance of SARS COV-2 IgG Anti-N as an Independent Marker of Exposure to SARS COV-2 in an Unvaccinated West African Population
: Determination of previous SARS-COV-2 infection is hampered by the absence of a standardized test. The marker used to assess previous exposure is IgG antibody to the nucleocapsid (IgG anti-N), although it is known to wane quickly from peripheral blood. The accuracies of seven antibody tests (virus neutralization test, IgG anti-N, IgG anti-spike [anti-S], IgG anti–receptor binding domain [anti-RBD], IgG anti-N + anti-RBD, IgG anti-N + anti-S, and IgG anti-S + anti-RBD), either singly or in combination, were evaluated on 502 cryopreserved serum samples collected before the COVID-19 vaccination rollout in Kumasi, Ghana. The accuracy of each index test was measured using a composite reference standard based on a combination of neutralization test and IgG anti-N antibody tests. According to the composite reference, 262 participants were previously exposed; the most sensitive test was the virus neutralization test, with 95.4% sensitivity (95% CI: 93.6–97.3), followed by 79.0% for IgG anti-N + anti-S (95% CI: 76.3–83.3). The most specific tests were virus neutralization and IgG anti-N, both with 100% specificity. Viral neutralization and IgG anti-N + anti-S were the overall most accurate tests, with specificity/sensitivity of 100/95.2% and 79.0/92.1%, respectively. Our findings indicate that IgG anti-N alone is an inadequate marker of prior exposure to SARS COV-2 in this population. Virus neutralization assay appears to be the most accurate assay in discerning prior infection. A combination of IgG anti-N and IgG anti-S is also accurate and suited for assessment of SARS COV-2 exposure in low-resource settings.
- 4 October 2023
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 109 (4) , 890-894
Open AccessPerformance of SARS COV-2 IgG Anti-N as an Independent Marker of Exposure to SARS COV-2 in an Unvaccinated West African Population
: Determination of previous SARS-COV-2 infection is hampered by the absence of a standardized test. The marker used to assess previous exposure is IgG antibody to the nucleocapsid (IgG anti-N), although it is known to wane quickly from peripheral blood. The accuracies of seven antibody tests (virus neutralization test, IgG anti-N, IgG anti-spike [anti-S], IgG anti–receptor binding domain [anti-RBD], IgG anti-N + anti-RBD, IgG anti-N + anti-S, and IgG anti-S + anti-RBD), either singly or in combination, were evaluated on 502 cryopreserved serum samples collected before the COVID-19 vaccination rollout in Kumasi, Ghana. The accuracy of each index test was measured using a composite reference standard based on a combination of neutralization test and IgG anti-N antibody tests. According to the composite reference, 262 participants were previously exposed; the most sensitive test was the virus neutralization test, with 95.4% sensitivity (95% CI: 93.6–97.3), followed by 79.0% for IgG anti-N + anti-S (95% CI: 76.3–83.3). The most specific tests were virus neutralization and IgG anti-N, both with 100% specificity. Viral neutralization and IgG anti-N + anti-S were the overall most accurate tests, with specificity/sensitivity of 100/95.2% and 79.0/92.1%, respectively. Our findings indicate that IgG anti-N alone is an inadequate marker of prior exposure to SARS COV-2 in this population. Virus neutralization assay appears to be the most accurate assay in discerning prior infection. A combination of IgG anti-N and IgG anti-S is also accurate and suited for assessment of SARS COV-2 exposure in low-resource settings.
- 1 February 2021
- Published by Elsevier in Analytical Biochemistry
- Vol. 614, 114023
Affordable method for quality DNA for genomic research in low to middle-income country research settings
- 1 February 2021
- Published by Elsevier in Analytical Biochemistry
- Vol. 614, 114023
Affordable method for quality DNA for genomic research in low to middle-income country research settings
- 1 April 2017
- Published by SAGE Publications in Biopreservation and Biobanking
- Vol. 15 (2) , 99-102
H3Africa Biorepository Program: Supporting Genomics Research on African Populations by Sharing High-Quality Biospecimens
- 1 April 2017
- Published by SAGE Publications in Biopreservation and Biobanking
- Vol. 15 (2) , 99-102
H3Africa Biorepository Program: Supporting Genomics Research on African Populations by Sharing High-Quality Biospecimens